A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic

Abstract

Get full access to this article

View all access options for this article.

References

Chowdhury

Rathod

Gernsheimer

A rapid systematic review of clinical trials utilizing chloroquine and hydroxychloroquine as a treatment for COVID-19. Acad Emerg Med 2020; 27(6): 493–504.

Gautret

Lagier

Parola

, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020; 56: 105949.

Clinical Trials Arena. Coronavirus: Chloroquine yields positive data in Covid-19 trial, https://www.clinicaltrialsarena.com/news/coronavirus-covid-19-choroquine-data/ (2020, accessed 2 July 2020).

Keyhani

VA Remote and equitable access to COVID-19 healthcare delivery (VA-REACH TRIAL), https://clinicaltrials.gov/ct2/show/NCT04363203 (2020, accessed 2 July 2020).

Rosenberg

Dufort

Udo

, et al. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State. JAMA 2020; 323(24): 2493–2502.

Poschet

Perkett

Timmins

, et al. Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells. bioRxiv, https://www.biorxiv.org/content/10.1101/2020.03.29.008631v1.full (2020, acc-essed 2 July 2020).

García Vázquez

Mensa

Martínez

, et al. Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone. Eur J Clin Microbiol Infect Dis 2005; 24(3): 190–195.

VA Informatics Computing Infrastructure: Corporate Data Warehouse (CDW). Health Services Research Development, https://www.hsrd.research.va.gov/for_researchers/vinci/cdw.cfm (2014, accessed 1 September 2020).

Simpson

Kovacs

Stecker

EC.

Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19, https://www.acc.org/latest-in-cardiology/articles/2020/03/27/14/00/ventricular-arrhythmia-risk-due-to-hydroxychloroquine-azithromycin-treatment-for-covid-19. (2020, accessed 2 July 2020).

10.

Guan

, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708–1720.

11.

Del Amo

Polo

Moreno

, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study. Ann Intern Med 2020; 173(7): 536–541.

12.

Papadopoulos

Patoulias

Teperikidis

, et al. Colchicine as a potential therapeutic agent against cardiovascular complications of COVID-19: an exploratory review. SN Compr Clin Med 2020: 1–11.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.11 MB